This marks THREAD's third recent acquisition, including the inVibe deal announced early this year and the Modus Outcomes purchase from November.
The new service was designed to help patients connect with oncology providers, institutes and studies.
A clinical trial has shown that it can predict AD progression with 88% and 84% accuracy in American and Japanese patients, respectively.
A new study in The Lancet found that a deep-learning algorithm was able to detect vision-threatening retinopathy with 94.7% accuracy.
A development study published in JMIR describes the App Rating Inventory, which aims to help clinicians find high-quality tools to use with patients.
It has several features including virtual clinic, automated reminders, and appointment management.
Dr. Spencer Dorn, gastroenterologist, professor and vice chair of medicine for care innovation at the University of North Carolina, writes on the potential for innovation to change gastroenterology care.
Diligent Robotics CEO and cofounder Andrea Thomaz explains how her company's clinical support robot Moxi works and how its design informs its interactions with humans.
